Literature DB >> 3766311

Rheumatoid inflammation and joint destruction: cause and effect or parallel phenomena?

J D Williams, D L Scott, F B DeBrito, D A Willoughby, E C Huskisson.   

Abstract

Joint damage is a characteristic and important consequence of rheumatoid arthritis; it is usually considered to be a direct result of the inflammatory synovitis. This view implies that by treating actively the synovial inflammation subsequent joint damage will be reduced and the long-term outlook of patients with rheumatoid arthritis thus improved. However, there is relatively little clinical evidence that suppressing inflammation reduces rheumatoid joint damage. An alternative view is that the mechanisms causing inflammation and those leading to joint destruction are parallel processes related only indirectly. Considerable evidence supports such a concept. Clinical studies show radiological progression of the disease occurs despite improvements in measures of joint inflammation and a reduction in the levels of acute phase proteins. Damage can progress in either actively inflamed hot joints or cool swollen joints. Histopathologically the features of rheumatoid synovitis are non-specific, while the radiological pattern of joint damage is very characteristic. There is evidence that lymphocytic infiltration is not a poor prognostic finding, despite it being a typical feature of inflamed joints. Experimental studies also fail to show a close correlation between inflammation and cartilage damage: this is seen in experimental arthritis, coculture in vitro systems, and the air pouch model of cartilage damage. We suggest that attempts to improve the outcome of rheumatoid arthritis should not merely concentrate on controlling inflammation but should also seek to modify the associated connective tissue changes of the disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3766311     DOI: 10.1007/bf01964961

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  33 in total

1.  Oxy radicals, "peroxide tone" and inflammation.

Authors:  L G Cleland
Journal:  J Rheumatol       Date:  1984-12       Impact factor: 4.666

2.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

3.  Diagnostic specificity of synovial lesions.

Authors:  N S Cooper; A Soren; C McEwen; J L Rosenberger
Journal:  Hum Pathol       Date:  1981-04       Impact factor: 3.466

4.  Carrageenin-induced arthritis: V. A morphologic study of the development of inflammation in acute arthritis.

Authors:  V Santer; A Sriratana; D A Lowther
Journal:  Semin Arthritis Rheum       Date:  1983-11       Impact factor: 5.532

5.  Current understanding of rheumatoid arthritis.

Authors:  H G Fassbender
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

6.  Catabolin--a cartilage catabolic factor from synovium.

Authors:  J T Dingle
Journal:  Clin Orthop Relat Res       Date:  1981-05       Impact factor: 4.176

7.  Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus.

Authors:  S Shiozawa; K Shiozawa; T Fujita
Journal:  Arthritis Rheum       Date:  1983-04

8.  Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.

Authors:  D J McCarty; G F Carrera
Journal:  JAMA       Date:  1982-10-08       Impact factor: 56.272

9.  Anti-rheumatic drugs and joint damage in rheumatoid arthritis.

Authors:  D L Scott; P T Dawes; P D Fowler; K A Grindulis; M Shadforth; P A Bacon
Journal:  Q J Med       Date:  1985-01

10.  Mast cells in rheumatoid arthritis.

Authors:  A J Crisp
Journal:  J R Soc Med       Date:  1984-06       Impact factor: 18.000

View more
  4 in total

1.  Correlative histologic and arthroscopic evaluation in rheumatoid knee joints.

Authors:  A Zschäbitz; M Neurath; J Grevenstein; H Koepp; E Stofft
Journal:  Surg Endosc       Date:  1992 Nov-Dec       Impact factor: 4.584

2.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 3.  Assessing the progression of joint damage in rheumatoid arthritis.

Authors:  D L Scott; M Farr
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac.

Authors:  M A Hayward; G A Howard; R G Neuman; D D Wood; B M Weichman; D C Van Sickle
Journal:  Agents Actions       Date:  1989-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.